After yesterday’s announcement, Illumina shares edged up 0.3%, closing at $139.08. The company is heavily investing in innovations to make the NovaSeq platform stronger and more versatile ...
is now available and shipping to customers with broad compatibility across Illumina's NGS platform portfolio, including NextSeq 1000/2000, NovaSeq 6000, and NovaSeq X. The single-cell sample prep ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback